计划性卵母细胞冷冻保存的成本效益与患者视角:系统综述与荟萃分析
该研究系统检索2007年1月至2019年12月间PubMed/MEDLINE、Embase、Cochrane Database和PsychINFO数据库,最终纳入43项研究。研究发现计划性卵母细胞冷冻保存在35岁且使用率达60%时具有成本效益,在38岁时推迟该方案转而进行2个IVF周期更具成本效益;当前22-58个月内冻存卵母细胞的使用率仅15%, warmed banked oocytes的活产率为9%。患者普遍认为35岁前进行该方案理想,但对其流程和成功率认知不足。
要点
- 35岁且使用率60%时计划性卵母细胞冷冻保存具成本效益,38岁时推迟该方案改行2个IVF周期更优
- 当前22-58个月内冻存卵母细胞使用率仅15%, warmed banked oocytes活产率为9%
- 患者认为35岁前进行该方案理想,但认知不足且倾向高估成功率
核心结论
- 计划性卵母细胞冷冻保存是保存生育力的适宜方法,但知识差距导致使用不足,降低成本效益。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed/MEDLINE、Embase、Cochrane Database和PsychINFO数据库,纳入2007年1月至2019年12月间发表的43项研究。
主要发现
- 在35岁且使用率达60%时,计划性卵母细胞冷冻保存具有成本效益。
- 在37岁且必要时使用供精时,计划性卵母细胞冷冻保存具有成本效益。
- 在38岁时,推迟计划性卵母细胞冷冻保存转而进行2个IVF周期更具成本效益。
- 当前22-58个月内冻存卵母细胞的使用率高达15%。
- warmed banked oocytes的活产率为9%。
关键数值与推荐
- 成本效益评估条件:35岁且使用率60%,37岁且必要时使用供精;38岁推迟方案改行2个IVF周期更具成本效益。
- 冻存卵母细胞使用率:22-58个月内高达15%; warmed banked oocytes活产率9%。
临床怎么用
- 在线资源和主治医生是计划性卵母细胞冷冻保存的同等重要信息来源。
- 多数患者认为35岁前进行计划性卵母细胞冷冻保存理想,但未充分了解流程且倾向高估成功率。
局限性
- 广泛推广计划性卵母细胞冷冻保存的主要障碍是担心潜在健康影响或成功率有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Advances in vitrification techniques have enabled planned oocyte cryopreservation ('Planned OC'). OBJECTIVES: To explore the cost-efficiency and utilisation of planned OC, as well as patients' perspectives on the process. SEARCH STRATEGY: A systematic search in PubMed/MEDLINE, Embase, Cochrane Database and PsychINFO, for all relevant studies published between January 2007 and December 2019. SELECTION CRITERIA: The protocol followed PRISMA guidelines in PECO format, and was registered with PROSPERO. DATA COLLECTION AND ANALYSIS: Two independent reviewers evaluated all manuscripts for inclusion eligibility. Authors were contacted for missing data. Included studies were assessed for risk of bias and for heterogeneity. Weighted effects were measured and plotted. MAIN RESULTS: The search yielded 12 545 records, of which 43 were included. Planned OC is cost-efficient at 35, assuming 60% utilisation; and at 37 assuming utilising donor sperm when necessary. At 38 it is cost-efficient to defer planned OC in favour of undergoing 2 IVF cycles. Currently, utilisation of banked-oocytes within 22-58 months, is up to 15%. Nine percent of warmed banked oocytes result in life births. Online resources and treating physicians are equally important sources of information regarding planned OC. Most patients think planned OC is ideal before age 35 and are not fully aware of what the process entails and tend to overestimate the success rates. The main barrier to wider endorsement of planned OC is being wary of potential health implications or of limited success. CONCLUSION: Planned OC is an adequate method for preserving fertility. However, knowledge gaps result in under-utilisation leading to reduced cost-efficiency. TWEETABLE ABSTRACT: Identifying facilitators and barriers for wider adoption of banking oocytes can enhance the cost-efficiency of this modality.
引用
- Fuchs Weizman N, Baram S, Montbriand J, et al. Planned oocyte cryopreservation (Planned OC): systematic review and meta-analysis of cost-efficiency and patients' perspective. BJOG. 2020. PMID: 33021076. doi:10.1111/1471-0528.16555
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。